Results 221 to 230 of about 28,675 (247)

Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis

Drugs, 2019
Teriflunomide (Aubagio®) is a disease-modifying immunomodulatory drug with anti-inflammatory properties that selectively and reversibly inhibits the mitochondrial enzyme dihydro-orotate dehydrogenase, with consequent inhibition of de novo pyrimidine synthesis and reduced lymphocyte proliferation.
openaire   +2 more sources

Alemtuzumab for relapsing-remitting multiple sclerosis

The Lancet Neurology, 2014
Richard A, Diaz, Sally, Doss, Martyn J, Burke, Elisabeth, George, Amanda I, Adler   +4 more
openaire   +2 more sources

Risk factors for relapse in relapsing remitting multiple sclerosis

British Journal of Neuroscience Nursing, 2021
Joanna Harrison, James Edward Hill
exaly  

Exploring the Relationship between Antioxidant Enzymes, Oxidative Stress Markers, and Clinical Profile in Relapsing–Remitting Multiple Sclerosis

Antioxidants, 2023
Agnieszka Piwowar, Justyna Chojdak-Łukasiewicz, Sławomir Budrewicz   +2 more
exaly  

Gut Microbiota as a Potential Predictive Biomarker in Relapsing-Remitting Multiple Sclerosis

Genes, 2022
BEATRIZ Ruzafa-Costas, Pedro Sanchez Pellicer, Laura Navarro   +2 more
exaly  

The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades

Multiple Sclerosis and Related Disorders, 2022
Cristina Masuet-Aumatell, Lucia Romero Pinel, Sérgio Martinez Yelamos   +2 more
exaly  

High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial

EClinicalMedicine, 2023
Emmanuelle Waubant, Sandra Cassard, Andrew Goodman   +2 more
exaly  

Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review

International Journal of Molecular Sciences, 2021
Angela Dziedzic, Joanna Saluk-Bijak, Elżbieta Miller   +2 more
exaly  

Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis

International Journal of Molecular Sciences, 2023
Doina Manu, Smaranda Maier, Laura Barcutean   +2 more
exaly  

Relapsing-Remitting Multiple Sclerosis

2017
Kathleen L. Fuchs, John DeLuca
openaire   +1 more source